1. Circulating tumor DNA as a biomarker and liquid biopsy in head and neck squamous cell carcinoma. Issue 7 (15th March 2018) Authors: Payne, Karl; Spruce, Rachel; Beggs, Andrew; Sharma, Neil; Kong, Anthony; Martin, Timothy; Parmar, Satyesh; Praveen, Prav; Nankivell, Paul; Mehanna, Hisham Journal: Head & neck Issue: Volume 40:Issue 7(2018) Page Start: 1598 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Microfluidic based circulating tumour cell isolation using the Parsortix platform in head and neck squamous cell carcinoma. Issue 10 (December 2020) Authors: Payne, Karl; Brooks, Jill; Spruce, Rachel; Batis, Nikolaos; Taylor, Graham; Nankivell, Paul; Mehanna, Hisham Journal: British journal of oral and maxillofacial surgery Issue: Volume 58:Issue 10(2020) Page Start: e159 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Phase I trial of WEE1 inhibition with chemotherapy and radiotherapy as adjuvant treatment, and a window of opportunity trial with cisplatin in patients with head and neck cancer: the WISTERIA trial protocol. Issue 3 (16th March 2020) Authors: Kong, Anthony; Good, James; Kirkham, Amanda; Savage, Joshua; Mant, Rhys; Llewellyn, Laura; Parish, Joanna; Spruce, Rachel; Forster, Martin; Schipani, Stefano; Harrington, Kevin; Sacco, Joseph; Murray, Patrick; Middleton, Gary; Yap, Christina; Mehanna, Hisham Journal: BMJ open Issue: Volume 10:Issue 3(2020) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗